CervoMed Inc.
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -193.9% | – | – | – | – | – | – | – | – | – | – | – | |
| – | +51.1% | +32.3% | +165.1% | -53.1% | +24.5% | +6.9% | +37.6% | -41.3% | +2.4% | +16.9% | +3.7% | – | |
| – | -121.1% | – | -114.3% | – | -1,263.3% | – | -158.3% | – | +14.1% | -124.5% | – | – | |
| – | -20.0% | -100.0% | – | -100.0% | – | – | – | -100.0% | – | – | – | – | |
| – | – | – | – | – | +257.6% | -42.0% | -104.7% | – | -29.1% | +43.5% | -67.2% | – | |
| – | -100.8% | – | – | -100.0% | -100.0% | – | – | -100.0% | – | – | +136,951.9% | – | |
| – | – | – | – | -162.2% | – | +19.6% | -245.2% | – | -207.6% | – | – | – | |
| – | -193.9% | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 9, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.